Arcadia Biosciences (RKDA) disclosed Thursday a definitive securities exchange agreement to combine with Roosevelt Resources in an all-stock deal.
Shares of Arcadia surged 138% as intraday trading volume catapulted to nearly 65.8 million from a daily average of about 15,000.
Protara Therapeutics (TARA) said Thursday its investigational therapy TARA-002 demonstrated a so-called complete response rate of 72% at six months in a phase 2 trial involving patients with non-muscle invasive bladder cancer.
Shares more than doubled as intraday trading volume soared to over 99.8 million from a daily average of more than 196,000.
ZSpace (ZSPC) shares debuted on Nasdaq Thursday with an opening price of $5.80, above the initial public offering price of $5.
The shares recently changed hands at $16.01 apiece, up more than 220% from the IPO price, with an intraday trading volume of about 1.07 million shares.
Price: 6.80, Change: +3.99, Percent Change: +141.85
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。